Found 14 results
Filters: Author is W.Y. Zhang  [Clear All Filters]
Y. L. Yang, Wang, J. G., Wang, D. X., Zhang, W. Y., Liu, X. J., Cao, J., and Yang, S. L., Analysis of an “off-ladder” allele at the Penta D short tandem repeat locus, vol. 14, pp. 15096-15101, 2015.
Y. P. Zhang, Sun, S. M., Fu, H. T., Ge, X. P., Qiao, H., Zhang, W. Y., Xiong, Y. W., Jiang, S. F., Gong, Y. S., and Jin, S. B., Characterization of the male-specific lethal 3 gene in the oriental river prawn, Macrobrachium nipponense, vol. 14, pp. 3106-3120, 2015.
H. Qiao, Xiong, Y. W., Jiang, S. F., Fu, H. T., Sun, S. M., Jin, S. B., Gong, Y. S., and Zhang, W. Y., Gene expression profile analysis of testis and ovary of oriental river prawn, Macrobrachium nipponense, reveals candidate reproduction-related genes, vol. 14, pp. 2041-2054, 2015.
F. J. Li, Jiang, F. W., Bai, H. K., Fu, H. T., Jin, S. B., Sun, S. M., Qiao, H., and Zhang, W. Y., Genomic cloning, expression, and single nucleotide polymorphism association analysis of the insulin-like androgenic gland hormone gene in the oriental river prawn (Macrobrachium nipponense), vol. 14, pp. 5910-5921, 2015.
S. B. Jin, Fu, H. T., Jiang, S. F., Xiong, Y. W., Qiao, H., Zhang, W. Y., Gong, Y. S., and Wu, Y., Identification of androgenic gland microRNA and their target genes to discover sex-related microRNA in the oriental river prawn, Macrobrachium nipponense, vol. 14, pp. 18396-18406, 2015.
W. Y. Zhang, Jiang, S. F., Xiong, Y. W., Fu, H. T., Qiao, H., Sun, S. M., Gong, Y. S., and Jin, S. B., Molecular cloning and expression analysis of female sterile homeotic gene (fsh) in the oriental river prawn Macrobrachium nipponense, vol. 14, pp. 4318-4330, 2015.
S. F. Jiang, Zhang, Y. P., Sun, S. M., Gong, Y. S., Xiong, Y. W., Qiao, H., Zhang, W. Y., Jin, S. B., and Fu, H. T., Molecular cloning, characterization, and expression analysis of a Broad-Complex homolog during development in the oriental river prawn Macrobrachium nipponense, vol. 14, pp. 5141-5152, 2015.
H. Li, Wu, R. F., Qi, F., Xiao, A. M., Ma, Z., Hu, Y., Zhang, W. Y., Li, W., and Wang, Z. C., Postpartum pelvic floor function performance after two different modes of delivery, vol. 14, pp. 2994-3001, 2015.
B. Jiang, Zhu, Z. Z., Liu, F., Yang, L. J., Zhang, W. Y., Yuan, H. H., Wang, J. G., Hu, X. H., and Huang, G., STAT3 gene polymorphisms and susceptibility to non-small cell lung cancer, vol. 10, pp. 1856-1865, 2011.
Abdulghani J, Gu L, Dagvadorj A, Lutz J, et al. (2008). Stat3 promotes metastatic progression of prostate cancer. Am. J. Pathol. 172: 1717-1728. PMid:18483213    PMCid:2408430 Barrett JC, Fry B, Maller J and Daly MJ (2005). Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265. PMid:15297300 Barrett JC, Hansoul S, Nicolae DL, Cho JH, et al. (2008). Genome-wide association defines more than 30 distinct susceptibility loci for Crohn’s disease. Nat. Genet. 40: 955-962. PMid:18587394    PMCid:2574810 Bollrath J, Phesse TJ, von Burstin VA, Putoczki T, et al. (2009). gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. Cancer Cell 15: 91-102. PMid:19185844 Bowman T, Garcia R, Turkson J and Jove R (2000). STATs in oncogenesis. Oncogene 19: 2474-2488. PMid:10851046 Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, et al. (1999). Stat3 as an oncogene. Cell 98: 295-303. Darnell JE (2005). Validating Stat3 in cancer therapy. Nat. Med. 11: 595-596. PMid:15937466 Dauer DJ, Ferraro B, Song L, Yu B, et al. (2005). Stat3 regulates genes common to both wound healing and cancer. Oncogene 24: 3397-3408. PMid:15735721 Ferguson LR, Han DY, Fraser AG, Huebner C, et al. (2010). Genetic factors in chronic inflammation: single nucleotide polymorphisms in the STAT-JAK pathway, susceptibility to DNA damage and Crohn’s disease in a New Zealand population. Mutat. Res. 690: 108-115. PMid:20109474 Fletcher S, Drewry JA, Shahani VM, Page BD, et al. (2009). Molecular disruption of oncogenic signal transducer and activator of transcription 3 (STAT3) protein. Biochem. Cell Biol. 87: 825-833. PMid:19935868 Grivennikov SI and Karin M (2010). Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev. 21: 11-19. Horinaga M, Okita H, Nakashima J, Kanao K, et al. (2005). Clinical and pathologic significance of activation of signal transducer and activator of transcription 3 in prostate cancer. Urology 66: 671-675. PMid:16140113 Hsieh FC, Cheng G and Lin J (2005). Evaluation of potential Stat3-regulated genes in human breast cancer. Biochem. Biophys. Res. Commun. 335: 292-299. PMid:16081048 Hsu HS, Huang PI, Chang YL, Tzao C, et al. (2011). Cucurbitacin i inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells. Cancer 117: 2970-2985. PMid:21225866 Ito N, Eto M, Nakamura E, Takahashi A, et al. (2007). STAT3 polymorphism predicts interferon-alfa response in patients with metastatic renal cell carcinoma. J. Clin. Oncol. 25: 2785-2791. PMid:17602083 Jing N, Zhu Q, Yuan P, Li Y, et al. (2006). Targeting signal transducer and activator of transcription 3 with G-quartet oligonucleotides: a potential novel therapy for head and neck cancer. Mol. Cancer Ther. 5: 279-286. PMid:16505101 Karin M (2006). Nuclear factor-kappaB in cancer development and progression. Nature 441: 431-436. PMid:16724054 Kreil S, Waghorn K, Ernst T, Chase A, et al. (2010). A polymorphism associated with STAT3 expression and response of chronic myeloid leukemia to interferon alpha. Haematologica 95: 148-152. PMid:20065083    PMCid:2805737 Lai SY and Johnson FM (2010). Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: implications for future therapeutic approaches. Drug Resist. Updat. 13: 67-78. PMid:20471303 Lin Q, Lai R, Chirieac LR, Li C, et al. (2005). Constitutive activation of JAK3/STAT3 in colon carcinoma tumors and cell lines: inhibition of JAK3/STAT3 signaling induces apoptosis and cell cycle arrest of colon carcinoma cells. Am. J. Pathol. 167: 969-980. Parkin DM, Bray F, Ferlay J and Pisani P (2005). Global cancer statistics, 2002. CA Cancer J. Clin. 55: 74-108. Sansone P, Storci G, Tavolari S, Guarnieri T, et al. (2007). IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J. Clin. Invest. 117: 3988-4002. PMid:18060036    PMCid:2096439 Scagliotti GV, Longo M and Novello S (2009). Nonsmall cell lung cancer in never smokers. Curr. Opin. Oncol. 21: 99-104. PMid:19532009 Shields PG (2002). Molecular epidemiology of smoking and lung cancer. Oncogene 21: 6870-6876. PMid:12362269 Siddiquee K, Zhang S, Guida WC, Blaskovich MA, et al. (2007a). Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity. Proc. Natl. Acad. Sci. U. S. A. 104: 7391-7396. PMid:17463090    PMCid:1863497 Siddiquee KA, Gunning PT, Glenn M, Katt WP, et al. (2007b). An oxazole-based small-molecule Stat3 inhibitor modulates Stat3 stability and processing and induces antitumor cell effects. ACS Chem. Biol. 2: 787-798. PMid:18154266 Stephens M, Smith NJ and Donnelly P (2001). A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 68: 978-989. PMid:11254454 Turkson J (2004). STAT proteins as novel targets for cancer drug discovery. Expert. Opin. Ther. Targets. 8: 409-422. PMid:15469392 Vaclavicek A, Bermejo JL, Schmutzler RK, Sutter C, et al. (2007). Polymorphisms in the Janus kinase 2 (JAK)/signal transducer and activator of transcription (STAT) genes: putative association of the STAT gene region with familial breast cancer. Endocr. Relat. Cancer 14: 267-277. PMid:17639043 Weerasinghe P, Garcia GE, Zhu Q, Yuan P, et al. (2007). Inhibition of Stat3 activation and tumor growth suppression of non-small cell lung cancer by G-quartet oligonucleotides. Int. J. Oncol. 31: 129-136. PMid:17549413 Yang L, Parkin DM, Li LD, Chen YD, et al. (2004). Estimation and projection of the national profile of cancer mortality in China: 1991-2005. Br. J. Cancer 90: 2157-2166. PMid:15150609    PMCid:2409509 Yin W, Cheepala S, Roberts JN, Syson-Chan K, et al. (2006). Active Stat3 is required for survival of human squamous cell carcinoma cells in serum-free conditions. Mol. Cancer 5: 15. PMid:16603078    PMCid:1502137 Yin ZJ, Jin FG, Liu TG, Fu EQ, et al. (2010). Overexpression of STAT3 potentiates growth, survival, and radioresistance of non-small-cell lung cancer (NSCLC) cells. J. Surg. Res. Doi: 10.1016/j.jss.2010.03.053. PMid:20605584 Yu H and Jove R (2004). The STATs of cancer - new molecular targets come of age. Nat. Rev. Cancer 4: 97-105. PMid:14964307 Yu H, Pardoll D and Jove R (2009). STATs in cancer inflammation and immunity: a leading role for STAT3. Nat. Rev. Cancer 9: 798-809. PMid:19851315